Search Results 251-260 of 17394 for methyldopa
Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...
About this study. This is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not ...
About this study. Skeletal muscle abnormalities (sarcopenia) and frailty are common complications seen in patients with end-stage liver disease.
The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy ...
Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.
A Study Of The Safety And Effectiveness Of NEOD001 For Treating Previously Treated Patients With Persistent Cardiac Dysfunction Related To Light Chain ...
A Multi-center Study A Single IV Infusion Of Allogeneic MPCs In Patients With Rheumatoid Arthritis And Incomplete Response To At Least One TNF Alpha Inhibitor.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
... methyldopa, tetrabenazine, deutetrabenazine, valbenazine, or reserpine. The subject has received a vaccination within 14 days before administration of the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.